Small Scale, High Interest Long Pharmaceuticals operates a 75,000 square foot facility with a track record of NDA/ANDA approvals and capabilities across formulation development, analytical and process development, clinical trial material manufacturing, packaging, and stability storage. This combination indicates a potential fit for contract development and manufacturing services, especially for smaller biotech and specialty pharma clients seeking proven regulatory experience without scale-up delays.

Diverse Formulation Expertise The company's experience spans liquids, suspensions, semi-solids, and tablets, suggesting opportunities to cross-sell comprehensive CMO services to firms requiring multi-portfolio development and manufacturing under one partner, reducing vendor fragmentation for clients with varied product pipelines.

API Sourcing Capability Long offers API sourcing for prescription and OTC products, creating a potential value proposition for firms seeking integrated supply chain solutions—from API sourcing to finished dosage form manufacturing—especially attractive to mid-market players aiming to consolidate suppliers.

Regulatory Track Record With staff responsible for multiple NDA/ANDA approvals at the facility, the company can position itself as a regulatory-savvy partner for clients pursuing similar approvals, offering risk- and speed-to-market advantages in development and manufacturing programs.

Strategic Fit for Small/Mid Caps Given revenue under $1M and a lean employee base, Long Pharmaceuticals is well-suited to target small to mid-sized pharmaceutical companies that require cost-efficient, compliant manufacturing and development services without large-scale capacity commitments. This presents an opportunity for growth through tiered service offerings and flexible engagement models.